What You Should Know:
- Genemoda cloud-based workspace collaboration software for biopharma R&D teams, today announced it raised $4.5 million in seed funding, co-led by defy.vc and LDV Partnerswith participation from Dolby Family Ventures and Vulcan/Cercano Ventures.
- Genemod digitizes data capture and workflows, so scientists can collaborate easily across an organization to accelerate life sciences R&D.
Digitize Research Workflows in Minutes
Legacy R&D software and other traditional methods are decentralized, disorganized and inefficient, ultimately resulting in higher healthcare costs. Genemod is working to be the solution to this problem by building a dynamic cloud-based research platform designed for research teams to house their entire R&D lifecycle: from data acquisition and project documentation to inventory management and reporting. The intuitive interface allows users to easily visualize their data and track progress and updates – including what changes are made by whom.
In the past year, Genemod has expanded into the biopharma R&D space working with teams from startups to enterprise companies including AstraZeneca, Bristol-Myers, Merck, and more. Working across siloed spreadsheets, updating data in real time and collaborating on projects in disparate geographical locations are just a few examples of how teams using Genemod are able to eliminate busywork and other barriers so they can focus on developments in biopharma.